Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients.
UMass Chan Affiliations
Department of Medicine, Division of Geriatric MedicineMeyers Primary Care Institute
Document Type
Journal ArticlePublication Date
2004-09-01Keywords
AgedAntilipemic Agents
Coronary Disease
Diabetes Mellitus
Female
Health Maintenance Organizations
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypertension
Insurance, Pharmaceutical Services
Male
Mortality
New England
Retrospective Studies
Treatment Refusal
Health Services Research
Medicine and Health Sciences